EGFR and ovarian carcinoma: Ueno et al., found that silencing ADAM9 induces apoptosis in cisplatin-resistance ovarian cancer cells through impaired EGFR signaling; moreover, the treatment of neutralizing antibody of ADAM9 has the same inhibitory effect to cisplatin-resistance ovarian cancer cell as well [111].